New Support for Ovarian Suppression with Endocrine Therapy in Premenopausal Breast Cancer
UBM Medica,
September 27, 2019 The addition of 2 years of ovarian function suppression (OFS) to tamoxifen (Nolvadex, Soltamox) yielded…
September 27, 2019 The addition of 2 years of ovarian function suppression (OFS) to tamoxifen (Nolvadex, Soltamox) yielded…
meeting of the American Society of Clinical Oncology was held from June 1 to 5 in Chicago and attracted approximately 20,000…
The 54th Annual Meeting of the American Society of Clinical Oncology The annual meeting of the American Society of Clinical…
The annual meeting of the American Society of Clinical Oncology was held from June 1 to 5 in Chicago and attracted…